Observational studyJournal of infusion nursing : the official publication of the Infusion Nurses Society
Primary Intravenous Set Consumption Across 3 Branded Infusion Pumps.
Nancy Hedlund, Shishir Sarangpur, Shannon Kayler, Kathy OʼBrien, Idal Beer
Abstract readObservational Study
In one paragraphObservational study in Journal of infusion nursing : the official publication of the Infusion Nurses Society. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 3 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
5 authors at 1 institution in 2 countries.
Nancy HedlundBaxter Healthcare Corporation, Deerfield, Illinois (Ms Kayler, Ms O'Brien, and Dr Beer); Creativ-Ceutical, Chicago, Illinois (Mr Sarangpur); and health economics and outcomes research independent consultant, Libertyville, Illinois (Ms Hedlund). Nancy Hedlund, MBA, BSPharm, is a PhD candidate in public health sciences at the University of Illinois, Chicago, and an independent consultant in health economics and outcomes research. At the time of this study she was associate director, Global Health Economics and Outcomes Research at Baxter Healthcare Corporation. She previously provided informatics support for Deloitte; led a consultant team at Hospira, Inc, responsible for intravenous medication systems; and practiced professionally as a pharmacist. Shishir Sarangpur, MS, BSPharm, is a research analyst at Creativ-Ceutical and has a background as a pharmacist. He is experienced in health outcomes/comparative effectiveness research and economic modeling, including in vascular thromboembolism, breast cancer, hyperlipidemia, and diabetes. Previously, he was a research technologist in pharmacy practice at the University of Illinois and an intern at Takeda Pharmaceuticals. Shannon Kayler, BSN, RN, is a senior clinical manager at Baxter Healthcare. She continues to practice as a hospital operating room nurse a few days a month. She participates in human factors studies and in design and deployment of Baxter products for the global marketplace. Before coming to Baxter, she practiced in the operating room, as well as in the postanesthesia care unit. Kathy O'Brien, MSN, RN, APRN-BC, is a senior clinical services manager with Baxter Healthcare's Clinical Center of Excellence. She has more than 25 years of hospital experience in medical-surgical nursing and more than 10 years of experience as a nurse consultant in the medical device industry. She maintains American Nurses Credentialing Center certification as an adult health clinical nurse specialist. Idal Beer, MD, MBA, MPH, is global medical director, therapeutic area lead, at Baxter Healthcare Corporation. His background is in internal medicine and critical care medicine. His interests are in the areas of techniques and technologies intended to reduce bloodstream infections, medication errors, and costs associated with intravenous therapy.
Shishir Sarangpur
Shannon Kayler
Kathy OʼBrien
Idal Beer
Health Economics and Outcomes Research (United Kingdom) · GB
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
This retrospective study of 6426 hip replacement, coronary artery bypass graft, and colectomy surgeries across 23 US hospitals found that intravenous (IV) set designs that can be interchanged for use both in gravity-fed and automated pump delivery systems are replaced less frequently than IV sets designed for use primarily by one delivery method. Semistructured interviews with nurses highlighted the impact of set design on nursing workflow when moving between gravity-fed and pump-based administration. Use of interchangeable, single-design IV sets across gravity and automated infusions minimizes disruptions to closed systems, may reduce nurses being distracted from patients' clinical needs when replacing sets, and may yield supply cost savings.
Indexed as
Administration, IntravenousHumansInfusion PumpsInfusions, IntravenousInterviews as TopicNurse's RolePatient SafetyRetrospective Studies
Identifiers
PMID28682999
PMCPMC5625969
OpenAlexW2727973589
What OpenQuestion holds
Textmetadata
Read underepoch 390